Disrupting Biofilms on Human Kidney Stones–A Path Toward Reducing Infectious Complications During Stone Surgery
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202403470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Daniel Massana Roquero und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA. Hauptthemen laut MEDLINE: Biofilms, Kidney Calculi, Chitosan, Urinary Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: NIDDK NIH HHS, NIH HHS, Urology Care Foundation Research Scholar Award.
Abstract (Originalsprache)
Kidney stones are a common disorder associated with significant morbidity and often requires surgical intervention. Pathogenic bacteria are found in almost 40% of stones, where they form biofilms that are protected from systemic antibiotic treatments. Stone surgeries disperse biofilms resulting in up to 30% of patients developing postoperative urinary tract infections and 15% developing sepsis. This work is based on the hypothesis that chitosan, an antimicrobial polymer, can eradicate bacterial biofilms present in the stone and potentially serve as an adjunct to irrigation during stone surgery. First, fresh patient‐derived kidney stone fragments ( n = 56) are collected from stone surgeries. A total of 32% of stones are colonized, predominantly with Enterococcus faecalis , Escherichia coli , and Proteus mirabilis . A short, clinically relevant, chitosan treatment reduces the bacterial burden on colonized stones by over 90% in all specimens tested, regardless of stone composition and bacterial strain. To assess this approach toxicity, ex vivo human ureters and in vivo porcine bladders are exposed to topical chitosan irrigation. No toxic or pathological abnormalities other than urothelial exfoliation are noted. In conclusion, chitosan effectively disrupts kidney stone‐associated bacterial biofilms with minimal urothelial toxicity and may provide an effective and safe approach to reducing postoperative complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
- Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
- Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
ORCID-Profile: Joseph C Liao
Förderung
- NIDDK NIH HHS
- NIH HHS
- Urology Care Foundation Research Scholar Award
- National Institutes of Health
Zitieren
APA
Massana Roquero, D., Holton, G. H., Ge, T. J., Kornberg, Z., Mach, K. E., Rodriguez, G., La, V., Lau, H., Sun, R., Chang, T. C., Conti, S., & Liao, J. C. (2025). Disrupting Biofilms on Human Kidney Stones–A Path Toward Reducing Infectious Complications During Stone Surgery. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403470
Vancouver
Massana Roquero D, Holton GH, Ge TJ, Kornberg Z, Mach KE, Rodriguez G, et al. Disrupting Biofilms on Human Kidney Stones–A Path Toward Reducing Infectious Complications During Stone Surgery. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403470
BibTeX
@article{MassanaRoquero2025,
author = {Massana Roquero, Daniel and Holton, Grace H and Ge, T Jessie and Kornberg, Zachary and Mach, Kathleen E and Rodriguez, Gabriella and La, Vinh and Lau, Hubert and Sun, Ryan and Chang, Timothy C and Conti, Simon and Liao, Joseph C},
title = {Disrupting Biofilms on Human Kidney Stones–A Path Toward Reducing Infectious Complications During Stone Surgery},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202403470}
}
EUVIMED